AI Engines For more Details: Perplexity Kagi Labs You
Depression: SAM-e has been investigated as a potential treatment for depression. Studies suggest that SAM-e may help alleviate symptoms of depression by increasing levels of neurotransmitters such as serotonin, dopamine, and norepinephrine in the brain. Some research indicates that SAM-e may be as effective as conventional antidepressants in improving mood.
Osteoarthritis: SAM-e has shown promise in the treatment of osteoarthritis, a degenerative joint disease characterized by cartilage breakdown and inflammation. SAM-e may help reduce pain, stiffness, and inflammation in individuals with osteoarthritis. It is believed to work by supporting cartilage repair and reducing the production of inflammatory molecules in the joints.
Liver Health: SAM-e plays a crucial role in liver function and may help protect against liver damage caused by various factors, including alcohol consumption, medication use, and liver disease. SAM-e has been studied for its potential hepatoprotective effects and its ability to support liver detoxification pathways.
Fibromyalgia: Some studies suggest that SAM-e supplementation may help improve symptoms of fibromyalgia, a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, and mood disturbances. SAM-e may help reduce pain and fatigue in individuals with fibromyalgia and improve overall well-being.
Cognitive Function: SAM-e may have neuroprotective properties and may help support cognitive function and mental clarity. Some research indicates that SAM-e supplementation may benefit individuals with cognitive impairment or age-related cognitive decline. It may also help improve mood and cognitive symptoms in conditions such as Alzheimer's disease and dementia.
Mood Disorders: In addition to depression, SAM-e has been studied for its potential therapeutic effects on other mood disorders, including anxiety and bipolar disorder. SAM-e may help stabilize mood and reduce symptoms of anxiety and mania in individuals with bipolar disorder. However, more research is needed to fully understand its effects on mood disorders.
Fatty Liver Disease: SAM-e may be beneficial in the management of non-alcoholic fatty liver disease (NAFLD), a condition characterized by the accumulation of fat in the liver. SAM-e may help improve liver function, reduce liver inflammation, and prevent the progression of NAFLD to more severe liver conditions such as non-alcoholic steatohepatitis (NASH) and cirrhosis.
Cardiovascular Health: Some studies suggest that SAM-e may have cardioprotective effects and may help reduce the risk of cardiovascular diseases such as heart disease and stroke. SAM-e may help lower levels of homocysteine, an amino acid associated with an increased risk of cardiovascular events when elevated.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Bacillus aeolius | Increases |
| species | Bacillus horti | Increases |
| species | Bacillus infernus | Increases |
| species | Bacillus pumilus | Increases |
| species | Bacillus thermotolerans | Increases |
| species | Escherichia coli | Increases |
| species group | Bacillus cereus group | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Lysinibacillus | genus | Increases |
| 0 | 1 | Escherichia | genus | Increases |
| 0 | 1 | Escherichia coli O20:H12 | no rank | Increases |
| 0 | 1 | Escherichia coli O2:K1:H5 | no rank | Increases |
| 0 | 1 | Escherichia coli O19:H7 | no rank | Increases |
| 0 | 1 | Escherichia coli O155:H21 | no rank | Increases |
| 0 | 1 | Escherichia coli O170:H18 | no rank | Increases |
| 0 | 1 | Escherichia coli O15:H12 | no rank | Increases |
| 0 | 1 | Escherichia coli O1:K1:H7 | no rank | Increases |
| 0 | 1 | Escherichia coli O55:H7 | no rank | Increases |
| 0 | 1 | Escherichia coli O68:H12 | no rank | Increases |
| 0 | 1 | Escherichia coli O7:H15 | no rank | Increases |
| 0 | 1 | Escherichia coli O85:H1 | no rank | Increases |
| 0 | 1 | Escherichia coli O18ac:H14 | no rank | Increases |
| 0 | 1 | Escherichia coli O78:H51 | no rank | Increases |
| 0 | 1 | Escherichia coli O2:K1:H7 | no rank | Increases |
| 0 | 1 | Escherichia coli O2:K1:H4 | no rank | Increases |
| 0 | 1 | Escherichia coli O84:H7 | no rank | Increases |
| 0 | 1 | Escherichia coli O158:H23 | no rank | Increases |
| 0 | 1 | Escherichia coli O80:H26 | no rank | Increases |
| 0 | 1 | Escherichia coli O139:H1 | no rank | Increases |
| 0 | 1 | Escherichia coli O141:H4 | no rank | Increases |
| 0 | 1 | environmental samples | no rank | Increases |
| 0 | 1 | environmental samples | no rank | Increases |
| 0 | 1 | environmental samples | no rank | Increases |
| 0 | 1 | Escherichia coli O145:H34 | no rank | Increases |
| 0 | 1 | Escherichia coli O16:H48 | no rank | Increases |
| 0 | 1 | unclassified Bacillus (in: firmicutes) | no rank | Increases |
| 0 | 1 | unclassified Escherichia | no rank | Increases |
| 0 | 1 | unclassified Kluyvera | no rank | Increases |
| 0 | 1 | Escherichia coli O25:H16 | no rank | Increases |
| 0 | 1 | Escherichia coli O145 | serogroup | Increases |
| 0 | 1 | Escherichia coli O157 | serogroup | Increases |
| 0 | 1 | Escherichia coli O119 | serogroup | Increases |
| 0 | 1 | Escherichia coli O43 | serogroup | Increases |
| 0 | 1 | Escherichia coli O78 | serogroup | Increases |
| 0 | 1 | Escherichia coli O103 | serogroup | Increases |
| 0 | 1 | Escherichia coli O91 | serogroup | Increases |
| 0 | 1 | Escherichia coli O111 | serogroup | Increases |
| 0 | 1 | Escherichia coli O121 | serogroup | Increases |
| 0 | 1 | Escherichia coli O155 | serogroup | Increases |
| 0 | 1 | Escherichia coli O177 | serogroup | Increases |
| 0 | 1 | Escherichia coli O26 | serogroup | Increases |
| 0 | 1 | Escherichia coli O3 | serogroup | Increases |
| 0 | 1 | Escherichia coli O5 | serogroup | Increases |
| 0 | 1 | Escherichia coli O86 | serogroup | Increases |
| 0 | 1 | Escherichia coli O139:H28 | serotype | Increases |
| 0 | 1 | Escherichia coli O78:H4 | serotype | Increases |
| 0 | 1 | Escherichia coli O9:H10 | serotype | Increases |
| 0 | 1 | Escherichia coli O83:H1 | serotype | Increases |
| 0 | 1 | Escherichia coli O104:H4 | serotype | Increases |
| 0 | 1 | Escherichia coli O167:H26 | serotype | Increases |
| 0 | 1 | Escherichia coli O103:H2 | serotype | Increases |
| 0 | 1 | Escherichia coli O45:H2 | serotype | Increases |
| 0 | 1 | Escherichia coli O157:H- | serotype | Increases |
| 0 | 1 | Escherichia coli O6:H16 | serotype | Increases |
| 0 | 1 | Escherichia coli O10:H32 | serotype | Increases |
| 0 | 1 | Escherichia coli O89m:H10 | serotype | Increases |
| 0 | 1 | Escherichia coli O8:H8 | serotype | Increases |
| 0 | 1 | Escherichia coli O2:K2:H1 | serotype | Increases |
| 0 | 1 | Escherichia coli O44:H18 | serotype | Increases |
| 0 | 1 | Escherichia coli O39:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O15:H18 | serotype | Increases |
| 0 | 1 | Escherichia coli O152:H23 | serotype | Increases |
| 0 | 1 | Escherichia coli O6:K2:H1 | serotype | Increases |
| 0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Increases |
| 0 | 1 | Escherichia coli O7:K1 | serotype | Increases |
| 0 | 1 | Escherichia coli O25:H1 | serotype | Increases |
| 0 | 1 | Escherichia coli O25:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O1:H42 | serotype | Increases |
| 0 | 1 | Escherichia coli O7:H4 | serotype | Increases |
| 0 | 1 | Escherichia coli O2:H6 | serotype | Increases |
| 0 | 1 | Escherichia coli O126:H45 | serotype | Increases |
| 0 | 1 | Escherichia coli O145:H28 | serotype | Increases |
| 0 | 1 | Escherichia coli O26:H11 | serotype | Increases |
| 0 | 1 | Escherichia coli O99:H6 | serotype | Increases |
| 0 | 1 | Escherichia coli O112ab:H8 | serotype | Increases |
| 0 | 1 | Escherichia coli O111:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O150:H6 | serotype | Increases |
| 0 | 1 | Escherichia coli H20 | serotype | Increases |
| 0 | 1 | Escherichia coli O113:H21 | serotype | Increases |
| 0 | 1 | Escherichia coli O111:H- | serotype | Increases |
| 0 | 1 | Escherichia coli O89m:H9 | serotype | Increases |
| 0 | 1 | Escherichia coli O16:H6 | serotype | Increases |
| 0 | 1 | Escherichia coli O157:H7 | serotype | Increases |
| 0 | 1 | Escherichia coli O121:H19 | serotype | Increases |
| 0 | 1 | Escherichia coli O100:H21 | serotype | Increases |
| 0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Increases |
| 0 | 1 | Escherichia coli O103:H11 | serotype | Increases |
| 0 | 1 | Escherichia coli O103:H25 | serotype | Increases |
| 0 | 1 | Escherichia coli O104:H21 | serotype | Increases |
| 0 | 1 | Escherichia coli O111:H11 | serotype | Increases |
| 0 | 1 | Escherichia coli O111:H8 | serotype | Increases |
| 0 | 1 | Escherichia coli O112ac:H19 | serotype | Increases |
| 0 | 1 | Escherichia coli O114:H49 | serotype | Increases |
| 0 | 1 | Escherichia coli O118:H16 | serotype | Increases |
| 0 | 1 | Escherichia coli O121:H7 | serotype | Increases |
| 0 | 1 | Escherichia coli O123:H11 | serotype | Increases |
| 0 | 1 | Escherichia coli O127:H27 | serotype | Increases |
| 0 | 1 | Escherichia coli O127:H6 | serotype | Increases |
| 0 | 1 | Escherichia coli O128:H2 | serotype | Increases |
| 0 | 1 | Escherichia coli O128ac:H12 | serotype | Increases |
| 0 | 1 | Escherichia coli O145:H25 | serotype | Increases |
| 0 | 1 | Escherichia coli O145:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O146:H21 | serotype | Increases |
| 0 | 1 | Escherichia coli O153:H2 | serotype | Increases |
| 0 | 1 | Escherichia coli O156:H25 | serotype | Increases |
| 0 | 1 | Escherichia coli O157:H43 | serotype | Increases |
| 0 | 1 | Escherichia coli O157:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O165:H25 | serotype | Increases |
| 0 | 1 | Escherichia coli O174:H2 | serotype | Increases |
| 0 | 1 | Escherichia coli O174:H21 | serotype | Increases |
| 0 | 1 | Escherichia coli O174:H8 | serotype | Increases |
| 0 | 1 | Escherichia coli O176:H45 | serotype | Increases |
| 0 | 1 | Escherichia coli O177:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O26:H1 | serotype | Increases |
| 0 | 1 | Escherichia coli O28ac:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O29:H4 | serotype | Increases |
| 0 | 1 | Escherichia coli O32:H37 | serotype | Increases |
| 0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Increases |
| 0 | 1 | Escherichia coli O69:H11 | serotype | Increases |
| 0 | 1 | Escherichia coli O78:H12 | serotype | Increases |
| 0 | 1 | Escherichia coli O79:H7 | serotype | Increases |
| 0 | 1 | Escherichia coli O81:NM | serotype | Increases |
| 0 | 1 | Escherichia coli O86:H34 | serotype | Increases |
| 0 | 1 | Escherichia coli O91:H14 | serotype | Increases |
| 0 | 1 | Escherichia coli O91:NM | serotype | Increases |
| 0 | 1 | Escherichia coli ONT:H33 | serotype | Increases |
| 0 | 1 | Escherichia coli O1:HNT | serotype | Increases |
| 0 | 1 | Escherichia ruysiae | species | Increases |
| 0 | 1 | Kluyvera genomosp. 3 | species | Increases |
| 0 | 1 | Escherichia marmotae | species | Increases |
| 0 | 1 | Kluyvera intermedia | species | Increases |
| 0 | 1 | Escherichia fergusonii | species | Increases |
| 0 | 1 | Bacillus glycinifermentans | species | Increases |
| 0 | 1 | Bacillus aeolius | species | Increases |
| 0 | 1 | Bacillus aerius | species | Increases |
| 0 | 1 | Bacillus alcaliinulinus | species | Increases |
| 0 | 1 | Bacillus alkalicellulosilyticus | species | Increases |
| 0 | 1 | Bacillus alveayuensis | species | Increases |
| 0 | 1 | Bacillus aquiflavi | species | Increases |
| 0 | 1 | Bacillus arachidis | species | Increases |
| 0 | 1 | Bacillus arbutinivorans | species | Increases |
| 0 | 1 | Bacillus badius | species | Increases |
| 0 | 1 | Bacillus benzoevorans | species | Increases |
| 0 | 1 | Bacillus cabrialesii | species | Increases |
| 0 | 1 | Bacillus canaveralius | species | Increases |
| 0 | 1 | Bacillus carboniphilus | species | Increases |
| 0 | 1 | Bacillus coahuilensis | species | Increases |
| 0 | 1 | Bacillus djibelorensis | species | Increases |
| 0 | 1 | Bacillus ferrariarum | species | Increases |
| 0 | 1 | Bacillus fonticola | species | Increases |
| 0 | 1 | Bacillus freudenreichii | species | Increases |
| 0 | 1 | Bacillus gobiensis | species | Increases |
| 0 | 1 | Bacillus hackensackii | species | Increases |
| 0 | 1 | Bacillus haynesii | species | Increases |
| 0 | 1 | Bacillus horti | species | Increases |
| 0 | 1 | Bacillus infantis | species | Increases |
| 0 | 1 | Bacillus infernus | species | Increases |
| 0 | 1 | Bacillus intestinalis Tetz and Tetz 2017 | species | Increases |
| 0 | 1 | Bacillus isabeliae | species | Increases |
| 0 | 1 | Bacillus mediterraneensis | species | Increases |
| 0 | 1 | Bacillus methanolicus | species | Increases |
| 0 | 1 | Bacillus nematocida | species | Increases |
| 0 | 1 | Bacillus olivae | species | Increases |
| 0 | 1 | Bacillus pakistanensis | species | Increases |
| 0 | 1 | Bacillus pseudomegaterium | species | Increases |
| 0 | 1 | Bacillus rugosus | species | Increases |
| 0 | 1 | Bacillus shandongensis | species | Increases |
| 0 | 1 | Bacillus shivajii | species | Increases |
| 0 | 1 | Bacillus smithii | species | Increases |
| 0 | 1 | Bacillus solimangrovi | species | Increases |
| 0 | 1 | Bacillus thermoamyloliquefaciens | species | Increases |
| 0 | 1 | Bacillus thermoproteolyticus | species | Increases |
| 0 | 1 | Bacillus thermotolerans | species | Increases |
| 0 | 1 | Bacillus tianmuensis | species | Increases |
| 0 | 1 | Bacillus weihaiensis | species | Increases |
| 0 | 1 | Bacillus xiamenensis | species | Increases |
| 0 | 1 | Cytobacillus dafuensis | species | Increases |
| 0 | 1 | Kluyvera cryocrescens | species | Increases |
| 0 | 1 | Kluyvera georgiana | species | Increases |
| 0 | 1 | Bacillus safensis | species | Increases |
| 0 | 1 | Escherichia albertii | species | Increases |
| 0 | 1 | Bacillus pumilus | species | Increases |
| 0 | 1 | Kluyvera ascorbata | species | Increases |
| 1 | 0 | Escherichia coli | species | Increases |
| 1 | 0 | Lysinibacillus sphaericus | species | Increases |
| 0 | 1 | Bacillus altitudinis complex | species group | Increases |
| 0 | 1 | Bacillus cereus group | species group | Increases |
| 0 | 1 | Bacillus subtilis group | species group | Increases |
| 0 | 1 | Escherichia coli APEC O1 | strain | Increases |
| 0 | 1 | Escherichia coli IAI39 | strain | Increases |
| 0 | 1 | Escherichia coli ED1a | strain | Increases |
| 0 | 1 | Escherichia coli K-12 | strain | Increases |
| 0 | 1 | Escherichia coli UMNF18 | strain | Increases |
| 0 | 1 | Escherichia coli FAP1 | strain | Increases |
| 0 | 1 | Escherichia coli SE11 | strain | Increases |
| 0 | 1 | Escherichia coli O15:H11 | strain | Increases |
| 0 | 1 | Escherichia coli O178:H19 | strain | Increases |
| 0 | 1 | Escherichia coli O157:H16 | strain | Increases |
| 0 | 1 | Escherichia coli ATCC 8739 | strain | Increases |
| 0 | 1 | Escherichia coli O22:H8 | strain | Increases |
| 0 | 1 | Escherichia coli O169:H41 | strain | Increases |
| 0 | 1 | Escherichia coli VR50 | strain | Increases |
| 0 | 1 | Escherichia coli UM146 | strain | Increases |
| 0 | 1 | Escherichia coli E110019 | strain | Increases |
| 0 | 1 | Escherichia coli IHE3034 | strain | Increases |
| 0 | 1 | Escherichia coli CFT073 | strain | Increases |
| 0 | 1 | Escherichia coli SE15 | strain | Increases |
| 0 | 1 | Escherichia coli LF82 | strain | Increases |
| 0 | 1 | Escherichia coli PMV-1 | strain | Increases |
| 0 | 1 | Escherichia coli APEC O2-211 | strain | Increases |
| 0 | 1 | Escherichia coli APEC IMT5155 | strain | Increases |
| 0 | 1 | Escherichia coli B str. REL606 | strain | Increases |
| 0 | 1 | Escherichia coli 'BL21-Gold(DE3)pLysS AG' | strain | Increases |
| 0 | 1 | Escherichia coli D9 | strain | Increases |
| 0 | 1 | Escherichia coli DORA_A_5_14_21 | strain | Increases |
| 0 | 1 | Escherichia coli G3/10 | strain | Increases |
| 0 | 1 | Escherichia coli HS | strain | Increases |
| 0 | 1 | Escherichia coli HVH 154 (4-5636698) | strain | Increases |
| 0 | 1 | Escherichia coli HVH 175 (4-3405184) | strain | Increases |
| 0 | 1 | Escherichia coli KO11FL | strain | Increases |
| 0 | 1 | Escherichia coli M12 | strain | Increases |
| 0 | 1 | Escherichia coli M17 | strain | Increases |
| 0 | 1 | Escherichia coli M8 | strain | Increases |
| 0 | 1 | Escherichia coli MS 107-1 | strain | Increases |
| 0 | 1 | Escherichia coli MS 115-1 | strain | Increases |
| 0 | 1 | Escherichia coli Nissle 1917 | strain | Increases |
| 0 | 1 | Escherichia coli P12b | strain | Increases |
| 0 | 1 | Escherichia coli PCN033 | strain | Increases |
| 0 | 1 | Escherichia coli STEC_DG131-3 | strain | Increases |
| 0 | 1 | Escherichia coli TW11917 | strain | Increases |
| 0 | 1 | Escherichia coli UMEA 3271-1 | strain | Increases |
| 0 | 1 | Escherichia coli UMN026 | strain | Increases |
| 0 | 1 | Escherichia coli UTI89 | strain | Increases |
| 0 | 1 | Escherichia coli ECC-1470 | strain | Increases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Allergic Rhinitis (Hay Fever) | 0.6 | 0.6 | 0 |
| Allergies | 1.2 | -1.2 | |
| Allergy to milk products | 0.6 | 0.6 | 0 |
| Alzheimer's disease | 0.6 | 0.6 | 0 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | 1.2 | -1 |
| Ankylosing spondylitis | 1.2 | -1.2 | |
| Antiphospholipid syndrome (APS) | 0.6 | -0.6 | |
| Asthma | 0.6 | -0.6 | |
| Atherosclerosis | 0.6 | -0.6 | |
| Atrial fibrillation | 0.6 | 0.6 | |
| Autism | 1.2 | 0.6 | 1 |
| Autoimmune Disease | 0.6 | -0.6 | |
| benign prostatic hyperplasia | 0.6 | -0.6 | |
| Biofilm | 0.6 | -0.6 | |
| Bipolar Disorder | 0.6 | -0.6 | |
| Breast Cancer | 0.6 | -0.6 | |
| Carcinoma | 0.6 | -0.6 | |
| Celiac Disease | 0.6 | -0.6 | |
| Chronic Fatigue Syndrome | 0.6 | -0.6 | |
| Chronic Kidney Disease | 0.6 | -0.6 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.6 | -0.6 | |
| Chronic Urticaria (Hives) | 1.2 | -1.2 | |
| Coagulation / Micro clot triggering bacteria | 1.2 | -1.2 | |
| Colorectal Cancer | 0.6 | 1.5 | -1.5 |
| Constipation | 1.2 | -1.2 | |
| Coronary artery disease | 1.2 | -1.2 | |
| COVID-19 | 1.2 | -1.2 | |
| Crohn's Disease | 1.2 | -1.2 | |
| cystic fibrosis | 1.2 | -1.2 | |
| d-lactic acidosis (one form of brain fog) | 0.6 | -0.6 | |
| deep vein thrombosis | 1.2 | -1.2 | |
| Depression | 0.6 | 1.2 | -1 |
| Eczema | 0.6 | -0.6 | |
| Endometriosis | 0.6 | 1.2 | -1 |
| Epilepsy | 1.2 | -1.2 | |
| erectile dysfunction | 0.6 | -0.6 | |
| Functional constipation / chronic idiopathic constipation | 1.2 | -1.2 | |
| gallstone disease (gsd) | 1.2 | -1.2 | |
| Generalized anxiety disorder | 1.2 | -1.2 | |
| Heart Failure | 1.2 | -1.2 | |
| High Histamine/low DAO | 0.8 | -0.8 | |
| hypercholesterolemia (High Cholesterol) | 0.6 | -0.6 | |
| hyperglycemia | 1.2 | -1.2 | |
| hypertension (High Blood Pressure | 0.6 | -0.6 | |
| Hypothyroidism | 0.6 | -0.6 | |
| Hypoxia | 1.2 | -1.2 | |
| Inflammatory Bowel Disease | 0.6 | 1.2 | -1 |
| Intelligence | 0.6 | -0.6 | |
| Irritable Bowel Syndrome | 1.2 | -1.2 | |
| ischemic stroke | 0.6 | 0.6 | 0 |
| Liver Cirrhosis | 0.6 | 1.2 | -1 |
| Long COVID | 0.6 | -0.6 | |
| Lung Cancer | 0.6 | -0.6 | |
| Lymphoma | 0.6 | -0.6 | |
| Mast Cell Issues / mastitis | 0.6 | -0.6 | |
| Metabolic Syndrome | 1.2 | -1.2 | |
| Mood Disorders | 0.6 | 0.6 | 0 |
| Multiple Sclerosis | 0.6 | -0.6 | |
| myasthenia gravis | 0.6 | -0.6 | |
| Neuropathy (all types) | 0.6 | 0.6 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.6 | -0.6 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.2 | -1.2 | |
| Obesity | 1.2 | -1.2 | |
| obsessive-compulsive disorder | 1.2 | -1.2 | |
| Osteoarthritis | 0.6 | -0.6 | |
| Osteoporosis | 0.6 | -0.6 | |
| pancreatic cancer | 0.6 | -0.6 | |
| Parkinson's Disease | 0.6 | 1.2 | -1 |
| Polycystic ovary syndrome | 0.6 | -0.6 | |
| Psoriasis | 0.6 | -0.6 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.6 | -0.6 | |
| Rosacea | 0.3 | -0.3 | |
| Schizophrenia | 0.6 | -0.6 | |
| scoliosis | 0.6 | -0.6 | |
| Sjögren syndrome | 0.6 | -0.6 | |
| Slow gastric motility / Gastroparesis | 0.6 | -0.6 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | -0.6 | |
| Stress / posttraumatic stress disorder | 0.6 | -0.6 | |
| Systemic Lupus Erythematosus | 0.6 | -0.6 | |
| Type 1 Diabetes | 0.6 | -0.6 | |
| Type 2 Diabetes | 0.6 | 1.2 | -1 |
| Ulcerative colitis | 1.2 | -1.2 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]